US rescind approval for Avastin21st November 2011
US drug regulators say Avastin is not effective enough to justify risks of taking it.
Click on available sources in right hand menu to see the original article.
Share this page
Wednesday 23rd November 2011 @ 8:31
Avastin is a cancer drug manufactured by Genentech, a part of Roche Pharmaceuticals. The Food and Drug Administration approval for Avastin was conditional. The Food and Drug Administration allowed it to be used only pending certain studies. Now that those studies have been finished, the approval has been taken away. Here is the proof: Approval pulled for Avastin breast cancer drug
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: US rescind approval for Avastin
Author: Martine Hamilton
Article Id: 20380
Date Added: 21st Nov 2011